Independent Clinical Trial Confirms Safeback SBX Significantly Increases Avalanche Survival Time
Safeback has announced that the results of an independent, double-blind clinical trial of its SBX avalanche survival system have been published in the prestigious Journal of the American Medical Association (JAMA). The study, led by Eurac Research’s Institute for Mountain Emergency Medicine, demonstrated that the SBX system can increase survival time fivefold for individuals buried in an avalanche.
The trial, conducted in 2023 with complete independence from Safeback, involved 24 volunteers who were buried face-down under 50 cm of avalanche-density snow. Participants were randomly assigned to either a control group, using placebo SBX devices, or an SBX group, equipped with functioning SBX devices.
Key Findings from the JAMA-Published Study:
- Control Group: Four of 12 volunteers requested the experiment be stopped due to distress, and seven had their burials terminated after a median of 6.4 minutes due to oxygen saturation falling below 80 percent, as required by protocol.
- SBX Group: No participant buried with a functioning SBX device had their experiment stopped due to low oxygen saturation. Their median burial time was 35 minutes, reaching the maximum duration planned for the experiment.
- Conclusion: Researchers noted, “In a real-life situation, emergency services or the victim’s companions would likely have had more than five times as much time to respond [with SBX], and potential cardiac arrest would occur much later.”
Eurac Research has published its own press release with further details from the study.
March 2023, avalanche simulation in the Dolomites at an altitude of approximately 2000 m. Over fifty centimeters of snow covering 24 volunteers lying face down. Half of them have a device integrated into their backpacks that draws air from the snow surrounding their backpacks and pumps it into the upper chest area. The other half have similar backpacks, but with a non-functioning (sham) device. Of the “control group,” four of the 12 volunteers asked for the experiment to be stopped because they did not feel well, and seven remained buried for a median duration of 6.4 minutes before their oxygen saturation fell below 80 percent and the experiment was stopped as required by protocol. No trial in the group equipped with the functioning device was stopped due to oxygen saturation dropping below 80 percent: the median burial time was 35 minutes, the maximum duration planned for the experiment. (In one case, the test was stopped earlier, but not because of hypoxemia.) In other words, in a real-life situation, emergency services or the victim’s companions would likely have had more than five times as much time to respond, and potential cardiac arrest would occur much later. The details of the results were published in one of the most prestigious and widely read international medical-scientific journals, JAMA.
When the Norwegian company that manufactures the Safeback SBX device which is already on the market, approached Eurac Research to have it independently tested, it was clear that the international research team led by physician and researcher Giacomo Strapazzon would publish the results of the study in any case, regardless of the outcome. For the researchers, the experiment posed a significant challenge, as many participants were completely buried in snow, raising concerns that over two-thirds might require urgent excavation. The volunteer group – composed entirely of enthusiastic ski mountaineers, roughly half of them women – ranged from 23 to 54 years in age.
Despite the demanding conditions, the study was conducted under strict monitoring and safety protocols, and everything proceeded smoothly. Ahead of the coming winter season, after careful analysis and verification, the results of these extreme tests are being published and offer reassurance for all mountain enthusiasts.
“No device can replace precautionary measures,” explain Frederik Eisendle and Giacomo Strapazzon, lead authors of the study and members of the Eurac Research team. “Prevention remains the most important tool for saving lives in the mountains. However, our clinical trial shows that this device is highly effective in prolonging survival under the snow and can gain valuable time for rescue operations.”
“Considering that asphyxiation is fatal for about two-thirds of critically-buried avalanche victims and death occurs on average within the first 35 minutes, the fact that none of the people involved in the test fell below the 80 percent saturation threshold during this time is truly remarkable,” the physicians continue.
The tests were conducted by Eurac Research in collaboration with the University of Bergen, the Haukeland University Hospital (Norway), the Norwegian Air Ambulance Foundation, the Italian national search and rescue organization Corpo Nazionale del Soccorso Alpino e Speleologico (CNSAS), the WSL Institute for Snow and Avalanche Research SLF (Switzerland), the University Hospital Cologne (Germany), the Medical University of Innsbruck (Austria), and the University of Padua (Italy). Logistical support was provided by the Scuola Alpina Guardia di Finanza (SAGF)and the staff of the Rolle Pass ski lifts.
The device exploits the natural porosity of snow—a principle first demonstrated by the same research group—to deliver oxygen-rich air to the nose and mouth via an electric pump. Once activated by a handle on the backpack, the Safeback SBX supplies up to 150 liters of air per minute for as long as 90 minutes. This airflow allows even a small air pocket to sustain a buried person with patent airways for over 35 minutes, despite the accumulation of exhaled carbon dioxide.
“Safeback was founded with a goal-zero vision: a world without avalanche fatalities,” stated Tor Berge, Safeback’s CEO and Co-founder. “SBX is a critical step toward that future—not a miracle device, but a vital last line of defense. By supplying burial victims with a continuous supply of fresh air, SBX helps buried victims stay alive longer, giving rescuers more time to reach them alive. We know survival depends on more than one tool. That’s why SBX stands alongside continued education, advanced prevention methods, and cutting-edge rescue technologies. Together, these efforts bring us closer than ever to our vision.”
Safeback SBX is a patented, battery-powered air pump system that leverages the natural porosity of snow to circulate fresh, breathable air from the snowpack behind a buried victim’s back to their face via the backpack’s shoulder straps. This continuous airflow delays asphyxia, even in the absence of an air pocket, as demonstrated in the recent study.
Designed for simplicity and reliability, the lightweight SBX unit (520g) features only three moving parts, occupying approximately 0.75L in a compatible backpack’s main compartment. Activated by a T-shaped handle, similar to avalanche airbags, SBX offers a critical survival advantage at half the weight and cost of a standard airbag system. It operates for 90 minutes at -22°F / -30°C using readily available Energizer Ultimate Lithium AA batteries.
SBX is integrated into avalanche backpacks developed by leading outdoor brands. For the clinical trial, volunteers wore the Snow Pro Vest 8L from Db. Currently, SBX-equipped backpacks are available from Db, Raide Research, and Bergans of Norway through specialty retailers worldwide. Specialized products for avalanche professionals and military users are also available by special order.
Safeback is an innovative outdoor safety company dedicated to developing technologies that enhance survival in avalanche incidents. Through rigorous research and cutting-edge engineering, Safeback aims to contribute to a world with zero avalanche fatalities.
More here